Associations of Genetic Variants Contributing to Gut Microbiota Composition in Immunoglobin A Nephropathy

Associations of Genetic Variants Contributing to Gut Microbiota Composition in Immunoglobin A Nephropathy

ABSTRACT The gut microbiota has been implicated in immunoglobin A nephropathy (IgAN) because the intestinal immune response is assumed to be one of the disease triggers. Since the microbial composition is heritable, we hypothesize that genetic variants controlling gut microbiota composition may be a...

Full description

Bibliographic Details
Main Authors:	Jia-Wei He, Xu-Jie Zhou, Ya-Feng Li, Yan-Na Wang, Li-Jun Liu, Su-Fang Shi, Xiao-Hong Xin, Rong-Shan Li, Mario Falchi, Ji-Cheng Lv, Hong Zhang
Format:	Article
Language:	English
Published:	American Society for Microbiology 2021-02-01
Series:	mSystems
Subjects:	IgA nephropathy genetics microbiome quantitative trait loci gut microbiota Dialister
Online Access:	https://journals.asm.org/doi/10.1128/mSystems.00819-20

Similar Items

Potential Roles of Oral Microbiota in the Pathogenesis of Immunoglobin A Nephropathy
by: Jia-Wei He, et al.
Published: (2021-04-01)

The Significance of Crescents on the Clinical Features and Outcomes of Primary Immunoglobin A Nephropathy
by: Yongjing Du, et al.
Published: (2022-06-01)

Gut microbiota in Immunoglobulin A Nephropathy: a Malaysian Perspective
by: Agni Nhirmal Kumar Sugurmar, et al.
Published: (2021-04-01)

Systematic Microbiome Dysbiosis Is Associated with IgA Nephropathy
by: Fengtao Cai, et al.
Published: (2023-06-01)

Is There a Role for Gut Microbiome Dysbiosis in IgA Nephropathy?
by: Renato C. Monteiro, et al.
Published: (2022-03-01)

Gut Microbiome Characteristics in IgA Nephropathy: Qualitative and Quantitative Analysis from Observational Studies
by: Shisheng Han, et al.
Published: (2022-05-01)

Characteristics of patients with coexisting IgA nephropathy and membranous nephropathy
by: Pei Chen, et al.
Published: (2018-10-01)

The relationship between serum uric acid levels and glomerular ischemic lesions in patients with Immunoglobin A nephropathy-a analytical cross-sectional study
by: Bolong Fang, et al.
Published: (2022-07-01)

Reduced fecal short-chain fatty acids levels and the relationship with gut microbiota in IgA nephropathy
by: Lingxiong Chai, et al.
Published: (2021-06-01)

Gut Microbes in Immunoglobulin A Nephropathy and Their Potential Therapeutic Applications
by: Yi Wang, et al.
Published: (2022-05-01)

An Update on the Current State of Management and Clinical Trials for IgA Nephropathy
by: Chee Kay Cheung, et al.
Published: (2021-06-01)

Aberrant Gut Microbiome Contributes to Barrier Dysfunction, Inflammation, and Local Immune Responses in IgA Nephropathy
by: Yuyan Tang, et al.
Published: (2023-03-01)

Pathogenic role of glycan-specific IgG antibodies in IgA nephropathy
by: Yan-feng Zhao, et al.
Published: (2017-09-01)

Glomerular Galactose-Deficient IgA1(KM55) Positive May Predict Poorer Prognosis in Coexisting Primary Membranous Nephropathy and IgA Nephropathy Patients
by: Wenrong Cheng, et al.
Published: (2022-12-01)

History of IgA Nephropathy Mouse Models
by: Batoul Wehbi, et al.
Published: (2021-07-01)

IgA Nephropathy Associated with IgA Vasculitis Coexisting with Focal Segmental Glomerulosclerosis Tip Variant
by: Zitlali Guadalupe Paulín Zepeda, et al.
Published: (2023-07-01)

Gut-kidney axis in IgA nephropathy: Role on mesangial cell metabolism and inflammation
by: Mateus Justi Luvizotto, et al.
Published: (2022-11-01)

Associations of genetic variants contributing to gut microbiota composition in diabetic nephropathy
by: Xiao Lu, et al.
Published: (2023-12-01)

Concurrent IgA Nephropathy and Membranous Nephropathy, Is It an Overlap Syndrome?
by: Jia-Wei He, et al.
Published: (2022-03-01)

Corrigendum: Concurrent IgA nephropathy and membranous nephropathy, is it an overlap syndrome?
by: Jia-Wei He, et al.
Published: (2023-06-01)

Predictors of prognosis in IgA nephropathy
by: Yasuhiko Tomino
Published: (2012-10-01)

Monitoring Immune Responses in IgA Nephropathy: Biomarkers to Guide Management
by: Haresh Selvaskandan, et al.
Published: (2020-10-01)

The utility of glomerular C4d immunostaining in renal biopsies in patients with immunoglobulin A nephropathy. A clinicopathological study
by: Małgorzata Wągrowska-Danilewicz, et al.
Published: (2017-09-01)

Efficacy and safety of artesunate for patients with IgA nephropathy: a study protocol for a multicenter, double-blind, randomized, placebo-controlled trial
by: Qi Chen, et al.
Published: (2022-05-01)

Comparison of the effects of hydroxychloroquine and corticosteroid treatment on proteinuria in IgA nephropathy: a case-control study
by: Ya-zi Yang, et al.
Published: (2019-08-01)

Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy
by: Yoshihito Nihei, et al.
Published: (2023-04-01)

Efficacy and safety of immunosuppressive treatment in IgA nephropathy: a meta-analysis of randomized controlled trials
by: Zheng Zhang, et al.
Published: (2019-08-01)

Coagulation parameters are associated with the prognosis of immunoglobulin a nephropathy: a retrospective study
by: Ming Xia, et al.
Published: (2020-10-01)

Bacterial but Not Fungal Gut Microbiota Alterations Are Associated With Common Variable Immunodeficiency (CVID) Phenotype
by: Kristýna Fiedorová, et al.
Published: (2019-08-01)

Clinical Relevance of Serum Galactose Deficient IgA1 in Patients with IgA Nephropathy
by: Jin Sug Kim, et al.
Published: (2020-11-01)

Efficacy and safety of sequential immunosuppressive treatment for severe IgA nephropathy: A retrospective study
by: Mian-Na Luo, et al.
Published: (2023-03-01)

IgA Vasculitis and IgA Nephropathy: Same Disease?
by: Evangeline Pillebout
Published: (2021-05-01)

ISN Forefronts Symposium 2015: IgA Nephropathy, the Gut Microbiota, and Gut−Kidney Crosstalk
by: Lijuan Han, et al.
Published: (2016-09-01)

Fecal Microbiota Transplantation Modulates Renal Phenotype in the Humanized Mouse Model of IgA Nephropathy
by: Gabriella Lauriero, et al.
Published: (2021-10-01)

Increased plasma sVCAM-1 is associated with severity in IgA nephropathy
by: Zhu Li, et al.
Published: (2013-01-01)

Causal effects between gut microbiota and IgA nephropathy: a bidirectional Mendelian randomization study
by: Feihong Ren, et al.
Published: (2023-05-01)

Diabetes mellitus with a duration of 26 years combined with IgA nephropathy: A case report and literature review
by: Yan-Li Gou, et al.
Published: (2022-12-01)

Probiotics ameliorate IgA nephropathy by improving gut dysbiosis and blunting NLRP3 signaling
by: Jiaxing Tan, et al.
Published: (2022-08-01)

Effect of hydroxychloroquine in patients with IgA nephropathy with insufficient responses to immunosuppressive therapy: a retrospective case-control study
by: Chen Tang, et al.
Published: (2020-11-01)

Interactions between the Gut Microbiome and Mucosal Immunoglobulins A, M, and G in the Developing Infant Gut
by: Anders Janzon, et al.
Published: (2019-12-01)